| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 728038 | 2[(3,4-dicloro)benzylamino]-3-phenyl-5,7-diamino quinoxaline | 0.00970780973624031 | -0.35887074 |
| NSC 733504 | Everolimus | 0.00970780973624031 | 0.26131981 |
| NSC 736811 | Null | 0.00970780973624031 | -0.42317339 |
| NSC 740 | Methotrexate | 0.00970780973624031 | -0.46405794 |
| NSC 740024 | 4-(2-Benzylthio-4-chloro-5-methylbenzenesulfonyl)-5,7-dimeth yl-2,4-dihydro-[1,2,4]triazepin-3-ylideneamine | 0.00970780973624031 | -0.25277363 |
| NSC 747461 | Null | 0.00970780973624031 | 0.31705865 |
| NSC 756053 | Null | 0.00970780973624031 | 0.4188606 |
| NSC 756404 | GW843682X | 0.00970780973624031 | -0.33383803 |
| NSC 763059 | Paracymene-ruthenium(II)-[N-(3-(1H-imidazol-1-yl)propyl)-4-(1-(3,5,5,8,8-pentamethyl-5,6,7,8 tetrahydronaphthalen-2-yl)vinyl)benzamide] dichloride | 0.00970780973624031 | -0.31875994 |
| NSC 79093 | 5-Hydroxy-6,7,8,4'-tetramethoxyflavone | 0.00970780973624031 | -0.33024225 |